Effects of ibuprofen during 42-km trail running on oxidative stress, muscle fatigue, muscle damage and performance: a randomized controlled trial.

Raphael Fabricio de Souza, Dihogo Gama de Matos, Jymmys Lopes Dos Santos, Clésio Andrade Lima, Alexandre Reis Pires Ferreira, Giselle Moreno, Alan Santos Oliveira, Danielle Dutra Pereira, Beat Knechtle, Felipe J Aidar

Journal: Research in sports medicine (Print) 2024;32(3):400-410

PMID: 36154349

Abstract

Up to 75% of marathon runners ingest non-steroidal anti-inflammatory drugs (NSAIDs) during competition. Despite the doubt whether or not they contribute to performance, the effect of NSAID in endurance sports is unclear. We evaluated the effect of ibuprofen (IBU) use on oxidative stress, muscle damage, physical performance, and vertical jump of runners participating in a 42-km-trail running. The sample consisted of 12 men randomly divided into 2 groups: a placebo group (placebo) and an ibuprofen group (IBG). A 400-mg IBU capsule was administered to the IBG 15 min prior to the start of the trial and during the course after 5 h. In the intergroup analysis, placebo 70.1% increase (p < 0.0001; Cohen's d = 4.77) of the thiobarbituric acid reactive substances (TBARS); the IBG exhibited a 31.46% increase of the sulphhydryl groups (SH) (p = 0.024, Cohen's d = 0.27), 55% of squat jump (SJ) (p < 0.01; Cohen's d = 1.41) with no significant effect on creatine kinase (CK), pace, speed, and finish time. In summary, IBU had positive evidence on oxidative stress and muscle fatigue, but had no effect on physical performance and muscle damage.

Address: Department of Physical Education, Federal University of Sergipe - UFS, Sergipe, Brazil.; Group of Studies and Research of Performance, Sport, Health and Paralympic Sports - GEPEPS, the Federal University of Sergipe - UFS, Sergipe, Brazil.; Graduate Program in Master's level in Physical Education, Federal University of Sergipe - UFS, Sergipe, Brazil.; Group of Studies and Research of Performance, Sport, Health and Paralympic Sports - GEPEPS, the Federal University of Sergipe - UFS, Sergipe, Brazil.; Department of Physical Education, Federal University of Sergipe - UFS, Sergipe, Brazil.; Department of Physiology and Pharmacology, Center of Biosciences, Federal University of Pernambuco, Recife, Brazil.; Department of Physical Education, Federal University of Sergipe - UFS, Sergipe, Brazil.; Department of Physical Education, Federal University of Sergipe - UFS, Sergipe, Brazil.; Group of Studies and Research of Performance, Sport, Health and Paralympic Sports - GEPEPS, the Federal University of Sergipe - UFS, Sergipe, Brazil.; Department of Physiology and Pharmacology, Center of Biosciences, Federal University of Pernambuco, Recife, Brazil.; Department of Physiology and Pharmacology Inflammatory Process, Federal University of Sergipe-UFS, Sergipe, Brazil.; Institute of Primary Care, University of Zurich, Zurich, Switzerland.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.